Submissions from 2025
Multidisciplinary management strategies for recurrent brain metastasis after prior radiotherapy: An overview, Rupesh Kotecha and Alonso La Rosa
Clinical and Genetic Markers of Vascular Toxicity in Glioblastoma Patients: Insights from NRG Oncology RTOG-0825, Minesh Mehta
Submissions from 2024
An Update on H3K27M-altered Diffuse Midline Glioma: Diagnostic and Therapeutic Challenges in Clinical Practice, Eyub Akdemir, Yazmin Odia, Matthew Hall, Minesh Mehta, and Rupesh Kotecha
Comparative evaluation of the diagnostic and prognostic performance of CNSide™ versus standard cytology for leptomeningeal disease, Haley Appel, Muni Rubens, Mukesh Roy, Rupesh Kotecha, Matthew Hall, Minesh Mehta, Zhijian Chen, Manmeet Ahluwalia, and Yazmin Odia
Dosimetric comparison of magnetic resonance-guided radiation therapy, intensity-modulated proton therapy and volumetric-modulated arc therapy for distal esophageal cancer, Andrew Barsky, Jerry George, Andrew Wroe, Kathryn Mittauer, Adeel Kaiser, Roberto Herrera, Jen Yu, Alonso Gutierrez, Diane Alvarez, James McCulloch, Michael Kasper, Minesh Mehta, and Michael Chuong
Dosimetric comparison of magnetic resonance-guided radiation therapy, intensity-modulated proton therapy and volumetric-modulated arc therapy for distal esophageal cancer, Andrew Barsky, Andrew Wroe, Kathryn Mittauer, Adeel Kaiser, Roberto Herrera, Jen Yu, Alonso Gutierrez, Diane Alvarez, James McCulloch, Michael Kasper, Minesh Mehta, and Michael Chuong
In Reply to Cellini and Fiore, Michael Chuong
Quality and Safety Considerations for Adaptive Radiation Therapy: An ASTRO White Paper: ASTRO ART Safety White Paper, Michael Chuong
TCF4 as a potential prognostic biomarker and an anticancer target in gastric cancer, Michael Chuong
TCF4 as a potential prognostic biomarker and an anticancer target in gastric cancer, Michael Chuong
The Dust Has Finally Settled, but Is the View Any Clearer?, Michael Chuong
The Dust Has Finally Settled, but Is the View Any Clearer?, Michael Chuong
Upping the Ante in the Treatment of Gastrointestinal Cancer, Michael Chuong
Quality assurance of an established online adaptive radiotherapy program: patch and software upgrade, Michael Chuong, Rupesh Kotecha, Yonatan Weiss, Minesh Mehta, Alonso Gutierrez, and Kathryn Mittauer
SBRT vs. Conventional Radiotherapy for Painful Spinal Metastases: A Comparative Analysis of Randomized Trials and Practical Considerations, Omer Gal, Robert Rothrock, Alonso Gutierrez, Minesh Mehta, and Rupesh Kotecha
Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy for Painful Spinal Metastases: A Comparative Analysis of Randomized Trials and Practical Considerations, Omer Gal, Robert Rothrock, Alonso Gutierrez, Minesh Mehta, and Rupesh Kotecha
Corrigendum: A single-institution experience with 177Lu RPT workflow improvements and qualifying the SPECT/CT imaging for dosimetry, Jerry George, Ranjini Tolakanahalli, Santiago Aguirre, Taehyung Kim, and Vivek Mishra
Dosimetric comparison of magnetic resonance-guided radiation therapy, intensity-modulated proton therapy and volumetric-modulated arc therapy for distal esophageal cancer, Jerry George, Andrew Wroe, Kathryn Mittauer, Adeel Kaiser, Roberto Herrera, Jen Yu, Alonso Gutierrez, Diane Alvarez, James McCulloch, Michael Kasper, Minesh Mehta, and Michael Chuong
Corrigendum: A single-institution experience with 177Lu RPT workflow improvements and qualifying the SPECT/CT imaging for dosimetry, Siju George, Ranjini Tolakanahalli, Santiago Aguirre, and Vivek Mishra
Patient-specific quality assurance of dynamically-collimated proton therapy treatment plans, Alonso Gutierrez and Eduardo Pons
Patient-specific quality assurance of dynamically-collimated proton therapy treatment plans, Alonso Gutierrez, Eduardo Pons, and Andrew Wroe
Establishing Updated Safety Standards for Independent (99)(m)Tc-MAA SPECT/CT Treatment Planning in Radioembolization, Taehyung Kim, Ripal Gandhi, Ranjini Tolakanahalli, Raul Herrera, Michael Chuong, Alonso Gutierrez, and Diane Alvarez
Recent advances in Tumor Treating Fields (TTFields) therapy for glioblastoma, Rupesh Kotecha
Early experience and perioperative risk of GammaTile for upfront brain metastases: Report from a prospective multicenter study, Rupesh Kotecha and Manmeet Ahluwalia
How proton therapy fits into the management of adult intracranial tumors, Rupesh Kotecha, Alonso La Rosa De Los Rios, and Minesh Mehta
In Regard to Trifiletti et al, Rupesh Kotecha and Minesh Mehta
Multidisciplinary Management of Isocitrate Dehydrogenase-Mutated Gliomas in a Contemporary Molecularly Defined Era, Rupesh Kotecha and Minesh Mehta
Stereotactic Body Radiotherapy for liver metastases: Systematic review and meta-analysis with International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines, Rupesh Kotecha and Zhenwei Zhang
Emerging potential of tumor treating fields as a treatment modality for pancreatic cancer: a narrative review of therapeutic evolution, Tugce Kutuk, Adeel Kaiser, and Michael Chuong
Surgically targeted radiation therapy versus stereotactic radiation therapy: A dosimetric comparison for brain metastasis resection cavities, Tugce Kutuk, Rupesh Kotecha, Raul Herrera, D Jay Wieczorek, Zachary Fellows, Vibha Chaswal, Alonso LaRosa, Vivek Mishra, Michael McDermott, Vitaly Siomin, Minesh Mehta, Alonso Gutierrez, and Ranjini Tolakanahalli
Surgically targeted radiation therapy versus stereotactic radiation therapy: A dosimetric comparison for brain metastasis resection cavities, Tugce Kutuk, Rupesh Kotecha, Raul Herrera, D Jay Wieczorek, Zachary Fellows, Vibha Chaswal, Alonso La Rosa De Los Rios, Vivek Mishra, Michael McDermott, Vitaly Siomin, Minesh Mehta, Alonso Gutierrez, and Ranjini Tolakanahalli
Surgically targeted radiation therapy versus stereotactic radiation therapy: A dosimetric comparison for brain metastasis resection cavities, Tugce Kutuk, Rupesh Kotecha, Raul Herrera, D Jay Wieczorek, Zachary Fellows, Vibha Chaswal, Alonso La Rosa De Los Rios, Vivek Mishra, Michael McDermott, Vitaly Siomin, Minesh Mehta, Alonso Gutierrez, and Ranjini Tolakanahalli
Interdisciplinary Collaboration in Head and Neck Cancer Care: Optimizing Oral Health Management for Patients Undergoing Radiation Therapy, Tugce Kutuk, Alessandro Villa, and Noah Kalman
Interdisciplinary Collaboration in Head and Neck Cancer Care: Optimizing Oral Health Management for Patients Undergoing Radiation Therapy, Tugce Kutuk, Alessandro Villa, Noah Kalman, and Adeel Kaiser
Comparative evaluation of outcomes amongst different radiosurgery management paradigms for patients with large brain metastasis, Tugce Kutuk, Yanjia Zhang, Eyub Akdemir, Sreenija Yarlagadda, Ranjini Tolakanahalli, Matthew Hall, Alonso La Rosa De Los Rios, D Jay Wieczorek, Cecilia Lee, Haley Appel, Michael McDermott, Yazmin Odia, Manmeet Ahluwalia, Alonso Gutierrez, Minesh Mehta, Rupesh Kotecha, and Robert Press
Initial feasibility cohort of temporally modulated pulsed proton re-irradiation (TMPPR) for recurrent high-grade intracranial malignancies, Alonso LaRosa, Zachary Fellows, Andrew Wroe, Len Coutinho, Eduardo Pons, Nicole McAllister, Ranjini Tolakanahalli, Tugce Kutuk, Matthew Hall, Robert Press, Michael McDermott, Yazmin Odia, Manmeet Ahluwalia, Minesh Mehta, Alonso Gutierrez, and Rupesh Kotecha
Accelerated Hypofractionated Magnetic Resonance Guided Adaptive Radiation Therapy for Ultracentral Lung Tumors, Alonso La Rosa de los Rios, Kathryn Mittauer, Nema Bassiri-Gharb, Amy Rzepczynski, Michael Chuong, Sreenija Yarlagadda, Tugce Kutuk, Nicole McAllister, Matthew Hall, Alonso Gutierrez, Ranjini Tolakanahalli, Minesh Mehta, and Rupesh Kotecha
Clinical application of an institutional fractionated stereotactic radiosurgery (FSRS) program for brain metastases delivered with MRIdian(Ⓡ) BrainTx™, Alonso La Rosa De Los Rios, Kathryn Mittauer, D Jay Wieczorek, Cecilia Lee, Amy Rzepczynski, Michael Chuong, Tugce Kutuk, Nicole McAllister, Matthew Hall, Alonso Gutierrez, Ranjini Tolakanahalli, Minesh Mehta, and Rupesh Kotecha
Evaluation of a non-metallic dual-port expander for intensity modulated proton therapy, Kristen McConnell, Zachary Fellows, James Kraus, Mauricio Acosta, Joseph Panoff, Eduardo Pons, Alonso Gutierrez, and Andrew Wroe
Clinical and Genetic Markers of Vascular Toxicity in Glioblastoma Patients: Insights from NRG Oncology RTOG-0825, Minesh Mehta
Evaluating the sensitivity of EQ-5D-5L in patients with brain metastases: a secondary analysis of NRG CC001, Minesh Mehta
Implications and interchangeability of meningioma biomarkers for clinical trials and clinical practice, Minesh Mehta
In Reply to Halperin, Minesh Mehta
NRG-BN002: Phase I Study of Ipilimumab, Nivolumab, and the Combination in Patients with Newly Diagnosed GBM, Minesh Mehta
NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastoma, Minesh Mehta
The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wild type and -mutant lower grade gliomas, Minesh Mehta
The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wild type and -mutant lower grade gliomas, Minesh Mehta
The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wildtype and -mutant lower grade gliomas, Minesh Mehta
The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wildtype and -mutant lower grade gliomas, Minesh Mehta
Commissioning Intracranial Stereotactic Radiosurgery for a Magnetic Resonance-Guided Radiation Therapy (MRgRT) System: MR-RT Localization and Dosimetric End-to-End Validation, Kathryn Mittauer, Ranjini Tolakanahalli, Rupesh Kotecha, Michael Chuong, Minesh Mehta, Alonso Gutierrez, and Nema Bassiri-Gharb
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma, Yazmin Odia, Doured Daghistani, and Matthew Hall
Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort, Yazmin Odia and Matthew Hall
ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma, Yazmin Odia and Minesh Mehta
ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma, Yazmin Odia and Minesh Mehta
Proton Therapy: Current Status and Controversies, Robert Press and Minesh Mehta
Quantifying the Dosimetric Impact of Proton Range Uncertainties on RBE-Weighted Dose Distributions in Intensity-Modulated Proton Therapy for Bilateral Head and Neck Cancer, Suresh Rana, Noufal Manthala Padannayil, Hina Saeed, and Michael Kasper
Prophylactic Radiotherapy Of MInimally Symptomatic Spinal Disease (PROMISSeD): study protocol for a randomized controlled trial, Robert Rothrock, Maria Avendano, Susana Herrera, Haley Appel, Suyen Ramos, Amy Starosciak, Muni Rubens, Michael McDermott, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha
Pediatric Cranial Stereotactic Radiosurgery: Meta-Analysis and International Stereotactic Radiosurgery Society Practice Guidelines, Anshul Saxena, Md Ashfaq Ahmed, and Rupesh Kotecha
Multi-institutional report of trastuzumab deruxtecan and stereotactic radiosurgery for HER2 positive and HER2-low breast cancer brain metastases, Sreenija Yarlagadda, Reshma Mahtani, Manmeet Ahluwalia, and Rupesh Kotecha
Case report: Intrafraction dose-guided tracking for gastrointestinal organ-at-risk isotoxicity delivery on an MR-guided radiotherapy system, Sreenija Yarlagadda, Yonatan Weiss, Michael Chuong, Nema Bassiri Gharb, Alonso Gutierrez, Rupesh Kotecha, Minesh Mehta, and Kathryn Mittauer
Submissions from 2023
Tucatinib, Trastuzumab, and Capecitabine with Stereotactic Radiosurgery in Patients with Brain Metastases from Her-2 Positive Breast Cancer (TUTOR): A Multicenter Phase 1 Clinical Trial, Manmeet Ahluwalia, Atulya Khosla, Ahmad Ozair, Rupesh Kotecha, Michael McDermott, Minesh Mehta, Ana Sandoval Leon, and Reshma Mahtani
Prophylactic Cranial Irradiation in Small Cell Lung Cancer Patients in the Era of Magnetic Resonance Imaging: A Systematic Review and Meta-analysis, Manmeet Ahluwalia and Minesh Mehta
Evaluating the Diagnostic Performance of Leptomeningeal Diagnosis with CNSide™ Compared to Standard Cytology, Haley Appel, Anshul Saxena PhD, Rupesh Kotecha, Alexander Mohler, Matthew Hall, Manmeet Ahluwalia, Minesh Mehta, Yazmin Odia, and Serguei Castaneda
Commissioning Intracranial Stereotactic Radiosurgery (SRS) for an MR-GuidedRadiotherapy (MRgRT) System: MR-RT Localization and Dosimetric End-to-End Validation, Nema Bassiri-Gharb, Ranjini Tolakanahalli, Rupesh Kotecha, Michael Chuong, Minesh Mehta, Alonso Gutierrez, and Kathryn Mittauer
Management of Brain Metastases: A Review of Novel Therapies, Shreyas Bellur, Atulya Khosla, Rupesh Kotecha, Michael McDermott, and Manmeet Ahluwalia
"Good-Catches Inventory to Interactive Data-Repository: Management and Analysis for Process Improvement", Vibha Chaswal, Cecilia Lee, D Jay Wieczorek, Alonso Gutierrez, and Ranjini Tolakanahalli
Evaluation of a Flat-Panel Based Compact Daily Quality Assurance Device for PencilBeam Scanning Proton Therapy, Daniel Cho, Mauricio Acosta, Eduardo Pons, Victor Chirinos, Andrew Wroe, and Alonso Gutierrez
Advances in MRI-Guided Radiation Therapy, Michael Chuong
Hits and Misses in Novel Pancreatic and Rectal Cancer Treatment Options, Michael Chuong
Treatment of Thymoma and Thymic Carcinoma with Proton Beam Therapy: Long-term Outcomes from the Proton Collaborative Group Registry, Michael Chuong
Prognostic value of neutrophil/lymphocyte count in pancreas patients receiving ablative MR-guided RT, Michael Chuong, Robert Herrera, Muni Rubens, Antonio Ucar, Fernando De Zarraga, Santiago Aparo, Sarah Joseph, Matthew Hall, Rupesh Kotecha, Adeel Kaiser, and Gigi Estevez
Ablative 5-fraction CT- versus MR-guided pancreatic SBRT: dosimetric effects of interfraction anatomic change, Michael Chuong, Adeel Kaiser, Matthew Hall, Rupesh Kotecha, Diane Alvarez, Nema Bassiri-Gharb, Alonso Gutierrez, James McCulloch, Kathryn Mittauer, Nicole McAllister, Ashley Fellows, Amy Rzepczynski, and Will Deere
Patterns of locoregional failure after ablative 5-fraction stereotactic MR-guided on-table adaptive radiation therapy for pancreatic cancer, Michael Chuong, Nicole McAllister, Surya Chundru, Robert Herrera, Adeel Kaiser, Matthew Hall, Rupesh Kotecha, Kathryn Mittauer, Diane Alvarez, James McCulloch, Nema Bassiri-Gharb, Alonso Gutierrez, Nicolas Carvallo, and Jason Extein
Phase II Trial of Stereotactic MR-guided On-table Adaptive Radiation Therapy for Borderline or Locally Advanced Pacreatic Cancer: Updated Safety & Efficacy Outcomes, Michael Chuong and Kathryn Mittauer
Quality of life after ablative 5-fraction radiation therapy from the phase II SMART pancreas trial, Michael Chuong and Kathryn Mittauer
Phase II trial of single-fraction SABR on 0.35T MRI-linac for thoracic, abdominal, and pelvic tumors, Michael Chuong, Kathryn Mittauer, Martin Tom, Noah Kalman, James McCulloch, Diane Alvarez, Paul Kaywin, Antonio Ucar, Federico Albrecht, Fernando De Zarraga, Santiago Aparo, Guilherme Rabinowits, Muni Rubens, Alonso Gutierrez, Rupesh Kotecha, and Carolina Rojas
Prospective Study Phase II Trial of Stereotactic MRI-Guided Adaptive Radiotherapy in 1 Fraction: Unplanned Interim Analysis, Michael Chuong, Kathryn Mittauer, Martin Tom, Noah Kalman, James McCulloch, Diane Alvarez, Paul Kaywin, Antonio Ucar, Federico Albrecht, Fernando De Zarraga, Santiago Aparo, Muni Rubens, Alonso Gutierrez, and Rupesh Kotecha
Multi-institutional outcomes of proton beam therapy for hepatocellular carcinoma from the Proton Collaborative Group REG001-09 stud, Michael Chuong and Muni Rubens
Proton craniospinal irradiation for patients with solid tumor leptomeningeal metastasis: Suggested planning approaches for prior irradiation patients, Zachary Fellows, Andrew Wroe, Rupesh Kotecha, Matthew Hall, Minesh Mehta, and Alonso Gutierrez